BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22939725)

  • 1. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer.
    Bendifallah S; Genin AS; Naoura I; Chabbert Buffet N; Clavel Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
    Am J Obstet Gynecol; 2012 Sep; 207(3):197.e1-8. PubMed ID: 22939725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lymphovascular space invasion on a nomogram for predicting lymph node metastasis in endometrial cancer.
    Koskas M; Bassot K; Graesslin O; Aristizabal P; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R
    Gynecol Oncol; 2013 May; 129(2):292-7. PubMed ID: 23480871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study.
    Kang S; Kang WD; Chung HH; Jeong DH; Seo SS; Lee JM; Lee JK; Kim JW; Kim SM; Park SY; Kim KT
    J Clin Oncol; 2012 Apr; 30(12):1329-34. PubMed ID: 22412131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
    Graesslin O; Abdulkarim BS; Coutant C; Huguet F; Gabos Z; Hsu L; Marpeau O; Uzan S; Pusztai L; Strom EA; Hortobagyi GN; Rouzier R; Ibrahim NK
    J Clin Oncol; 2010 Apr; 28(12):2032-7. PubMed ID: 20308667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis.
    Bendifallah S; Canlorbe G; Laas E; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Cortez A; Bleu G; Daraï E; Ballester M
    Ann Surg Oncol; 2015 Dec; 22(13):4224-32. PubMed ID: 25869227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.
    Gur AS; Unal B; Ozbek U; Ozmen V; Aydogan F; Gokgoz S; Gulluoglu BM; Aksaz E; Ozbas S; Baskan S; Koyuncu A; Soran A;
    Eur J Surg Oncol; 2010 Jan; 36(1):30-5. PubMed ID: 19535217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of nomograms designed to predict lymphatic dissemination in patients with early-stage endometrioid endometrial cancer: a multicenter study.
    Bendifallah S; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Huguet F; Cortez A; Daraï E; Ballester M
    Am J Obstet Gynecol; 2015 Jan; 212(1):56.e1-7. PubMed ID: 24983678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
    Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
    Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent external validation of radiotherapy and its impact on the accuracy of a nomogram for predicting survival of women with endometrial cancer.
    Koskas M; Bendifallah S; Luton D; Darai E; Rouzier R
    Gynecol Oncol; 2011 Nov; 123(2):214-20. PubMed ID: 21903248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
    Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
    Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival impact of lymphadenectomy stratified by nodal metastatic probability in endometrial cancer.
    Koskas M; Fournier M; Luton D; Darai E; Rouzier R
    Ann Surg Oncol; 2014 Jul; 21(7):2376-82. PubMed ID: 24590435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
    Specht MC; Kattan MW; Gonen M; Fey J; Van Zee KJ
    Ann Surg Oncol; 2005 Aug; 12(8):654-9. PubMed ID: 16021535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
    Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
    Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
    BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
    Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
    Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.